Annual Total Expenses:
$537.49M+$143.56M(+36.44%)Summary
- As of today, RXRX annual total expenses is $537.49 million, with the most recent change of +$143.56 million (+36.44%) on December 31, 2024.
- During the last 3 years, RXRX annual total expenses has risen by +$344.72 million (+178.82%).
- RXRX annual total expenses is now at all-time high.
Performance
RXRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Expenses:
$195.33M-$10.86M(-5.27%)Summary
- As of today, RXRX quarterly total expenses is $195.33 million, with the most recent change of -$10.86 million (-5.27%) on June 30, 2025.
- Over the past year, RXRX quarterly total expenses has increased by +$80.38 million (+69.93%).
- RXRX quarterly total expenses is now -5.27% below its all-time high of $206.19 million, reached on March 31, 2025.
Performance
RXRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RXRX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +36.4% | +69.9% |
| 3Y3 Years | +178.8% | +164.5% |
| 5Y5 Years | +737.8% | +972.2% |
RXRX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +178.8% | -5.3% | +161.6% |
| 5Y | 5-Year | at high | +737.8% | -5.3% | +737.0% |
| All-Time | All-Time | at high | +737.8% | -5.3% | +972.2% |
RXRX Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $195.33M(-5.3%) |
| Mar 2025 | - | $206.19M(+9.5%) |
| Dec 2024 | $537.49M(+36.4%) | $188.28M(+51.3%) |
| Sep 2024 | - | $124.44M(+8.3%) |
| Jun 2024 | - | $114.95M(+4.7%) |
| Mar 2024 | - | $109.83M(+0.3%) |
| Dec 2023 | $393.94M(+38.0%) | $109.55M(-0.1%) |
| Sep 2023 | - | $109.65M(+18.2%) |
| Jun 2023 | - | $92.73M(+13.1%) |
| Mar 2023 | - | $82.00M(+9.8%) |
| Dec 2022 | $285.41M | $74.66M(-1.3%) |
| Sep 2022 | - | $75.63M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $73.84M(+20.5%) |
| Mar 2022 | - | $61.28M(-9.2%) |
| Dec 2021 | $192.78M(+119.0%) | $67.46M(+37.9%) |
| Sep 2021 | - | $48.90M(+12.6%) |
| Jun 2021 | - | $43.43M(+31.7%) |
| Mar 2021 | - | $32.98M(+17.2%) |
| Dec 2020 | $88.03M(+37.2%) | - |
| Dec 2020 | - | $28.13M(+20.6%) |
| Sep 2020 | - | $23.34M(+28.1%) |
| Jun 2020 | - | $18.22M(-0.7%) |
| Mar 2020 | - | $18.34M |
| Dec 2019 | $64.15M | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual total expenses?
- What is the all-time high annual total expenses for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual total expenses year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly total expenses?
- What is the all-time high quarterly total expenses for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual total expenses?
The current annual total expenses of RXRX is $537.49M
What is the all-time high annual total expenses for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual total expenses is $537.49M
What is Recursion Pharmaceuticals, Inc. annual total expenses year-on-year change?
Over the past year, RXRX annual total expenses has changed by +$143.56M (+36.44%)
What is Recursion Pharmaceuticals, Inc. quarterly total expenses?
The current quarterly total expenses of RXRX is $195.33M
What is the all-time high quarterly total expenses for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly total expenses is $206.19M
What is Recursion Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
Over the past year, RXRX quarterly total expenses has changed by +$80.38M (+69.93%)